Studies have shown that P53 binds to the promoter region of SLC7A11 in many human cancer cell lines through experiment verification, thereby down-regulating its protein expression, reducing the inhibition of tumor cells on ferroptosis, and finally promoting ferroptosis. This evidence concerns the gene TP53 and cancer.